Prof. Ruben Abagyan is Professor of Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego. Dr. Abagyan and his group work in specialized in developing and utilizing techniques for structure-based discovery, molecular modeling, and optimization of potential drug candidates, identifying targets, large scale bioinformatics and bioinformatics. The applications include viral, cancer, neurodegeneration, parasitic, and endocrine diseases.

Dr. Duangrudee Tanramluk is an Assistant Professor in Structural Bioinformatics at Mahidol University in Thailand. She lead the development of a revolutionary AI systems for Drug Discovery: MANORAA & SIMFONEE packages. Her data-driven drug discovery platform enables in-depth and big picture analysis of small molecule drug discovery via programmable URL. Her field of expertise is on building software to decipher protein specificity and promiscuity. Her webservice fosters sustainability in drug design education and bring new hope for precision medicine.

Dr. Jiye Shi is the Associate Vice President, Global Head of Computational Design and Automation Platforms at Eli Lilly and Company. He is the world-class expert in AI-inspired biologics and small molecule drug discovery. His computational talents lead to the discovery of Romosozumab and Bimekizumab. He has developed novel structure-based AI/ML antibody design algorithms which led to the design of antibodies targeting a specific epitope and the design of dual-specific antibodies. He has established strong partnerships with academic and industrial partners, led to talents recruited by AI and biotech companies (e.g. DeepMind, BenevolentAI, Exscientia).

Dr Arun Prasad Pandurangan is a senior researcher at the Heart & Lung Research Institute, University of Cambridge. He is an expert in structural bioinformatics, genomics and modelling cryo-EM maps with specific interest in understanding the impacts of genetic mutations in disease and drug resistance. He is Associate Editors of BMC Bioinformatics, Computational and Structural Biotechnology Journal, etc.

Jiraporn Panmanee is currently a Lecturer at the Institute of Molecular Biosciences, Mahidol University. She possess a Ph.D. in Biological Sciences with research focuses on in silico structure-based drug design, neurotoxicity assessment of pesticides, structural biology, and neurobiology of neurodegenerative diseases. Her academic pursuit has focused on unraveling complexities in these domains to contribute to advancements in healthcare and environmental science.

Ittipat Meewan is Lecturer at the Institutes of Molecular Biosciences, Mahidol University. His current research focuses on computational-aided development of small molecules and peptide antivirals, targeting viruses such as SARS-CoV-2, HBV, HCV, ZIKV, DENV, and HPV. The primary techniques include molecular docking, molecular dynamics, and machine learning are employed for virtual screening of large libraries against target proteins and identify potential drug candidates which are then validated experimentally.